Correlation Between Lyra Therapeutics and Syndax Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Lyra Therapeutics and Syndax Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Lyra Therapeutics and Syndax Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Lyra Therapeutics and Syndax Pharmaceuticals, you can compare the effects of market volatilities on Lyra Therapeutics and Syndax Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Lyra Therapeutics with a short position of Syndax Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Lyra Therapeutics and Syndax Pharmaceuticals.
Diversification Opportunities for Lyra Therapeutics and Syndax Pharmaceuticals
0.69 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Lyra and Syndax is 0.69. Overlapping area represents the amount of risk that can be diversified away by holding Lyra Therapeutics and Syndax Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Syndax Pharmaceuticals and Lyra Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Lyra Therapeutics are associated (or correlated) with Syndax Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Syndax Pharmaceuticals has no effect on the direction of Lyra Therapeutics i.e., Lyra Therapeutics and Syndax Pharmaceuticals go up and down completely randomly.
Pair Corralation between Lyra Therapeutics and Syndax Pharmaceuticals
Given the investment horizon of 90 days Lyra Therapeutics is expected to under-perform the Syndax Pharmaceuticals. In addition to that, Lyra Therapeutics is 1.35 times more volatile than Syndax Pharmaceuticals. It trades about -0.1 of its total potential returns per unit of risk. Syndax Pharmaceuticals is currently generating about -0.07 per unit of volatility. If you would invest 1,921 in Syndax Pharmaceuticals on August 27, 2024 and sell it today you would lose (248.00) from holding Syndax Pharmaceuticals or give up 12.91% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Lyra Therapeutics vs. Syndax Pharmaceuticals
Performance |
| Timeline |
| Lyra Therapeutics |
| Syndax Pharmaceuticals |
Lyra Therapeutics and Syndax Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Lyra Therapeutics and Syndax Pharmaceuticals
The main advantage of trading using opposite Lyra Therapeutics and Syndax Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Lyra Therapeutics position performs unexpectedly, Syndax Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Syndax Pharmaceuticals will offset losses from the drop in Syndax Pharmaceuticals' long position.| Lyra Therapeutics vs. Eliem Therapeutics | Lyra Therapeutics vs. HCW Biologics | Lyra Therapeutics vs. Scpharmaceuticals | Lyra Therapeutics vs. Milestone Pharmaceuticals |
| Syndax Pharmaceuticals vs. Eliem Therapeutics | Syndax Pharmaceuticals vs. HCW Biologics | Syndax Pharmaceuticals vs. Scpharmaceuticals | Syndax Pharmaceuticals vs. Milestone Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Other Complementary Tools
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |